wentaosun310@gmail.com

OptHealth: Ophthalmic Screening

Launched in 2025.11 | Medical Device + AI Screening

Launched in 2025.11 | Medical Device + AI Screening

OptHealth: Ophthalmic Screening

Launched in 2025.11 | Medical Device + AI Screening

Background

Medical Device
AI Product
International Adaptation

OptHealth Inc.
Vistel
Airdoc

Role

Primary UX Designer Visual Designer Ongoing (North American deployment pending FDA regulatory approval)

Timeline

Sep 27, 2025

Background

Medical Device
AI Product
International Adaptation

OptHealth Inc.
Vistel
Airdoc

Role

Primary UX Designer Visual Designer Ongoing (North American deployment pending FDA regulatory approval)

Timeline

Sep 27, 2025

What It Is

What It Is

OptHealth is an AI-powered ophthalmic screening system for clinical environments. It analyzes retinal images to support physicians in early detection of diabetic retinopathy and cardiovascular risk indicators. The product is validated and live in Asian and European markets. The North American version is pending FDA-related regulatory approval. My focus was the North American adaptation: rethinking an existing product for a different regulatory environment and clinical context. Core engineering is led by the overseas team. I worked on the design and UX layer.

OptHealth is an AI-powered ophthalmic screening system for clinical environments. It analyzes retinal images to support physicians in early detection of diabetic retinopathy and cardiovascular risk indicators. The product is validated and live in Asian and European markets. The North American version is pending FDA-related regulatory approval. My focus was the North American adaptation: rethinking an existing product for a different regulatory environment and clinical context. Core engineering is led by the overseas team. I worked on the design and UX layer.

OptHealth is an AI-powered ophthalmic screening system for clinical environments. It analyzes retinal images to support physicians in early detection of diabetic retinopathy and cardiovascular risk indicators. The product is validated and live in Asian and European markets. The North American version is pending FDA-related regulatory approval. My focus was the North American adaptation: rethinking an existing product for a different regulatory environment and clinical context. Core engineering is led by the overseas team. I worked on the design and UX layer.

My Contribution

UX Design

  • Designed physician-facing UI: on-device interface, AI results report, and clinical workflow

  • Participated in cross-functional reviews with overseas product and engineering teams to align interface decisions with regulatory and workflow constraints

Regulatory Adaptation

  • Revised workflows and UX copy to meet FDA requirements and local clinical expectations

  • Shifted result language from diagnostic framing to possibility-based framing, reflecting the current approved indication scope

  • Reorganized the report hierarchy to serve different reader types, prioritizing clinicians who need to act quickly over those parsing raw AI parameters

Research Foundation

  • Competitive analysis of North American medical imaging products

  • FDA guidance documentation review

  • Cross-market product analysis comparing the Asian and European versions

Marketing and Visual Design

  • Produced marketing materials for Canadian market outreach

  • Supported preparation for the 2026 CES exhibition in Las Vegas, including localization of product-facing materials

Tools

  • Design: Figma, Adobe Photoshop, Illustrator, Premiere, CapCut

  • AI: ChatGPT, Claude, Cursor, Gemini

  • Collaboration: Notion, Miro, Google Drive

This project is under active development. Detailed process documentation is withheld in accordance with confidentiality agreements.

My Contribution

UX Design

  • Designed physician-facing UI: on-device interface, AI results report, and clinical workflow

  • Participated in cross-functional reviews with overseas product and engineering teams to align interface decisions with regulatory and workflow constraints

Regulatory Adaptation

  • Revised workflows and UX copy to meet FDA requirements and local clinical expectations

  • Shifted result language from diagnostic framing to possibility-based framing, reflecting the current approved indication scope

  • Reorganized the report hierarchy to serve different reader types, prioritizing clinicians who need to act quickly over those parsing raw AI parameters

Research Foundation

  • Competitive analysis of North American medical imaging products

  • FDA guidance documentation review

  • Cross-market product analysis comparing the Asian and European versions

Marketing and Visual Design

  • Produced marketing materials for Canadian market outreach

  • Supported preparation for the 2026 CES exhibition in Las Vegas, including localization of product-facing materials

Tools

  • Design: Figma, Adobe Photoshop, Illustrator, Premiere, CapCut

  • AI: ChatGPT, Claude, Cursor, Gemini

  • Collaboration: Notion, Miro, Google Drive

This project is under active development. Detailed process documentation is withheld in accordance with confidentiality agreements.

Create a free website with Framer, the website builder loved by startups, designers and agencies.